Drug intelligence / Profile preview

Homeo-GH

Development stage: Phase 1
Lead developer: HomeoTherapy
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

Homeo-GH is an investigational cell therapy developed by HomeoTherapy Co., Ltd. It consists of ex-vivo cultured adult human clonal mesenchymal stem cells (cMSC) derived from human bone marrow. The drug is being evaluated for its safety in the treatment of Graft versus Host Disease (GVHD).

Beyond the preview

Go deeper on Homeo-GH.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeo-GH.

Explore the full profile